Nature CommunicationsIn situ reprogramming of CAR-alveolar macrophages via liposomal nanomedicine for lung cancer immunotherapyHui LiChaoyi LyuXiaoyao CaiYufeng ZhangQian GuoYanbin ChenCuihong YangZujian FengYumin ZhangJianfeng Liu2026-06-12Full textDOI https://doi.org/10.1038/s41467-026-74162-1